Patient-Powered Precision – How Kraft Accelerator is positioning patients to improve clinical care, research
The Harvard Business School’s Kraft Precision Medicine Accelerator is tackling a series of initiatives that will position patients to help drive improvements in both clinical care and clinical research.
The accelerator was founded in 2015 with a $20 million donation from the Robert and Myra Kraft Family Foundation to speed the development of precision medicine approaches to get the right cancer drugs to the right patients. The accelerator is co-chaired by HBS Senior Fellow Richard Hamermesh and Kathy Giusti, founder and board member of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium.
Is It Time To Break Up Amazon, Apple, Facebook, or Google?
Can a Platform-Based Tech Giant Be Broken Up?
The answer to this month’s question of whether platform-based tech giants Amazon, Apple, Facebook, or Google should be broken up was a resounding “no.”
“TD in FL” put it succinctly with one of the age-old defences of capitalism: “No breakups! Why punish a company for doing the best job they can and succeed?”
Others argued that market definition is changing in ways that render United States anti-trust policy outdated in an increasingly global economy. As Craig Parietti & Partners put it, “We are now a global economy… China is already grabbing from the US the ‘largest home market’ advantage, allowing them to subsidize pricing globally. I guarantee that Tencent, Alibaba and others will fill the gap left by a misguided break-up.” David de Weese added, “It is not at all clear that they do not face competitors in Asia, India and other countries who will effectively threaten their apparent dominance, including in the US.”
